Skip to Main Content

Paper Details

Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.
Transl Lung Cancer Res
6
2021
Author NameAffiliation
Mary ZhangCenter for Cancer Research, National Cancer Institute
Mary ZhangCenter for Cancer Research, National Cancer Institute
Julie A HongCenter for Cancer Research, National Cancer Institute
Julie A HongCenter for Cancer Research, National Cancer Institute
Markku MiettinenCenter for Cancer Research, National Cancer Institute
Markku MiettinenCenter for Cancer Research, National Cancer Institute
Cuong Hoang-VuCenter for Cancer Research, National Cancer Institute
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
David S SchrumpCenter for Cancer Research, National Cancer Institute
David S SchrumpCenter for Cancer Research, National Cancer Institute
  • 1 - 11

Datasets